Anika Therapeutics | Crediti Commerciali

Prezzo Delle Azioni
14.40
Cambio Giornaliero
0.08 0.56%
Mensile
34.96%
Annuale
-14.59%
Q1 Previsione
13.92




Crediti Commerciali Cambiamento Data
Abbott USD 10.4B 166M 2025-09
Agenus USD 354K 53K 2025-03
Agios Pharmaceuticals USD 10.58M 5.55M 2025-12
Anika Therapeutics USD 21.99M 1.61M 2025-03
Arrowhead Research USD 218.87M 212.05M 2025-12
Enanta Pharmaceuticals USD 40.16M 1.52M 2024-12
Halozyme Therapeutics USD 441.27M 95.24M 2025-12
Heron Therapeutics USD 67.04M 6.9M 2024-09
Insmed USD 140.86M 75.6M 2025-12
Integra LifeSciences USD 278.85M 16.69M 2025-12
Intrexon USD 1.02M 559K 2024-06
J&J USD 17.61B 235M 2025-09
Karyopharm Therapeutics USD 31.78M 6.82M 2024-09
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
MacroGenics USD 69.23M 56.7M 2025-09
Merit Medical Systems USD 223.61M 7.9M 2025-12
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 397M 100M 2025-12
Smith & Nephew USD 1.48B 85M 2025-12
Stryker USD 4.04B 396M 2025-12
Surmodics USD 23.27M 790K 2024-09
Veracyte USD 44.66M 3.17M 2025-12
Xencor USD 29.3M 7.49M 2025-12
Zimmer Biomet Holdings USD 1.7B 106.1M 2025-12


Anika Therapeutics Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.